FMP

FMP

Enter

HRMY - Harmony Biosciences ...

photo-url-https://images.financialmodelingprep.com/symbol/HRMY.png

Harmony Biosciences Holdings, Inc.

HRMY

NASDAQ

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

32.72 USD

0 (0%)

HRMY Financial Statements

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Total Revenue

201.27M

186.04M

172.81M

154.62M

Cost of Revenue

54.41M

42.78M

38.1M

33.45M

Gross Profit

146.86M

143.26M

134.71M

121.17M

Operating Expenses

91.13M

81.55M

113.35M

69.14M

Research and Development

34.67M

25.39M

63.58M

22.19M

Selling, General & Administrative Expenses

56.47M

56.16M

49.77M

46.95M

Selling & Marketing Expenses

27.6M

27.58M

28.51M

27.23M

General & Administrative Expenses

28.86M

28.59M

27.22M

25.68M

Other Expenses

0

0

37k

-141k

Operating Income

55.73M

61.71M

21.36M

52.03M

Total Other Income/Expenses Net

428k

460k

338k

-248k

Income Before Tax

56.16M

62.17M

21.69M

51.78M

Income Tax

6.68M

16.08M

10.1M

13.45M

Net Income

49.48M

46.09M

11.59M

38.33M

Basic EPS

0.87

0.81

0.2

0.68

EPS Diluted

0.85

0.79

0.2

0.67

Basic Average Shares

57.1M

56.87M

56.8M

56.77M

Diluted Average Shares

58.22M

58.1M

57.54M

57.6M

EBITDA

66.33M

72.49M

27.41M

58.16M

Retained Earning Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Retained Earnings (Previous Year)

-47.26M

-93.35M

-104.94M

-143.28M

Net Income

49.48M

46.09M

11.59M

38.33M

Stock Repurchases

0

269k

-269k

0

Dividend Paid

0

0

0

0

Retained Earnings

2.22M

-47.26M

-93.35M

-104.94M

Other Distributions

49.48M

46.36M

11.32M

38.33M

PPE Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Gross PPE

1.26M

750k

3.26M

3.26M

Annual Depreciation

5.97M

5.97M

6.05M

6.12M

Capital Expenditure

-513k

-3k

-632k

-5k

Net PPE

-4.2M

-5.21M

-2.16M

-2.86M

Intangible and Goodwill Schedule

Quarter

2024 Q4

2024 Q3

2024 Q2

2024 Q1

Acquisitions and Adjustments

0

0

0

0

Goodwill (Previous Year)

0

0

0

0

Goodwill

0

0

0

0

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep